Compare OVID & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | VREX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 447.2M |
| IPO Year | 2017 | 2016 |
| Metric | OVID | VREX |
|---|---|---|
| Price | $2.80 | $18.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $4.60 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $7,252,000.00 | ★ $811,000,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | $19.34 | $3.88 |
| P/E Ratio | ★ N/A | $80.43 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.84 | $9.09 |
| 52 Week High | $3.11 | $18.63 |
| Indicator | OVID | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 63.71 | 90.71 |
| Support Level | $2.22 | $9.73 |
| Resistance Level | $3.05 | N/A |
| Average True Range (ATR) | 0.15 | 0.33 |
| MACD | 0.04 | 0.77 |
| Stochastic Oscillator | 86.67 | 98.20 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.